Commonwealth Equity Services’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.61M | Hold |
|
|||||
|
2025
Q2 | $923K | Buy |
|
|||||
|
2025
Q1 | $1.08M | Buy |
|
|||||
|
2024
Q4 | $635K | Hold |
|
|||||
|
2024
Q3 | $534K | Buy |
|
|||||
|
2024
Q2 | $421K | Hold |
|
|||||
|
2024
Q1 | $413K | Hold |
|
|||||
|
2023
Q4 | $439K | Buy |
|
|||||
|
2023
Q3 | $272K | Hold |
|
|||||
|
2023
Q2 | $383K | Hold |
|
|||||
|
2023
Q1 | $238 | Sell |
|
|||||
|
2022
Q4 | $195K | Hold |
|
|||||
|
2022
Q3 | $229K | Hold |
|
|||||
|
2022
Q2 | $226K | Hold |
|
|||||
|
2022
Q1 | $376K | Sell |
|
|||||
|
2021
Q4 | $577K | Buy |
|
|||||
|
2021
Q3 | $239K | Sell |
|
|||||
|
2021
Q2 | $409K | Buy |
|
|||||
|
2021
Q1 | $438K | Buy |
|
|||||
|
2020
Q4 | $468K | Buy |
|
|||||
|
2020
Q3 | $558K | Buy |
|
|||||
|
2020
Q2 | $244K | Buy |
|
|||||
|
2020
Q1 | $19K | Buy |
|